Healthcare News and Research

Latest Healthcare News and Research

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

The District of Columbia Department of Health has released a study by the George Washington University School of Public Health and Health Services investigating prescribing of antipsychotics to District seniors.

21 Oct 2013

First Edition: October 21, 2013

Today's headlines include the latest reports about how the Obama administration plans to make the necessary fixes in the health law's online insurance marketplace.

21 Oct 2013

WebMD signs agreement to repurchase all shares from Icahn Group

WebMD Health Corp., the leading source of health information, today announced that it has entered into an agreement to repurchase all of the shares of WebMD common stock beneficially owned by Carl C. Icahn and certain of his affiliates, at a purchase price of $32.08 per share, the NASDAQ Official Closing Price of WebMD's common stock on October 18, 2013.

21 Oct 2013

New collaborative project aims to discover genes underlying rare genetic diseases

...

21 Oct 2013

UL professor to lead €1.5M research programme on economics of personalised health

Leading Health Economist, John Forbes, has been appointed as Professor of Health Economics at the University of Limerick. His appointment has been supported by the Health Research Board. Professor Forbes becomes one of the first HRB Research Leaders and he will lead a €1.5 million programme of research into the economics of personalised health.

21 Oct 2013

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals, Inc. announced today that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients.

21 Oct 2013

HOYA Group's Vision Care Division expands operations in Romania

HOYA Group's Vision Care Division, a key player in the global market for ophthalmic lenses, announces the start of HOYA Lens Romania.

21 Oct 2013

GVI uses Toshiba’s Spot Fluoroscopy to reduce radiation exposure to patients and physicians

Gates Vascular Institute is now able to conduct safer exams using Spot Fluoroscopy, a cardiovascular X-ray dose management technology from Toshiba America Medical Systems, Inc. GVI utilizes Spot Fluoroscopy with its Infinix-i bi-plane to reduce radiation exposure to both patients and physicians.

21 Oct 2013

Researchers discover link between NOX4 enzyme and osteoporosis

Genkyotex, the leading developer of NOX enzyme inhibitors, announced today that a group of collaborators have discovered a link between the enzyme NOX4 and development of osteoporosis.

21 Oct 2013

Adolescents vaccination for pertussis linked with lower rates of infant hospitalizations

Widespread vaccination of adolescents for pertussis was associated with lower rates of infant hospitalizations for the respiratory infection than would have been expected had teens not been inoculated according to new research in Pediatrics.

21 Oct 2013

Research Institute receives Fast Track status for its gene therapy product for treatment of SMA

AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children's Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular atrophy (SMA).

19 Oct 2013

Tech experts say total overhaul of healthcare.gov may be needed

Beyond consumers' problems using the federal website, insurers are getting flawed enrollment data from the few who manage to sign up for plans, the Wall Street Journal reports.

19 Oct 2013

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced preliminary study results suggesting the potential for an RNA-based gene expression test to accurately detect the BRAF V600E gene mutation in thyroid nodule fine needle aspiration (FNA) samples.

19 Oct 2013

Viewpoints: Health marketplace already has eligibility verification; entitlement fight lies ahead

If I were an entrepreneur in Washington, I'd be racing to print a bunch of T-shirts that said, "My tea party Republican shut down the government, and all I got was this lousy income verification mandate."

19 Oct 2013

Unitedhealth says lower Medicare advantage payments forced smaller profit

The Minnetonka, Minn., company said government funding cuts to Medicare Advantage plans were one drag during the quarter, but it said overall medical costs remained in check (Terhune, 10/17).

19 Oct 2013

AMVI partners with ApolloMed to participate in Accountable Care Organization

Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), a physician-centric integrated healthcare delivery company, today announced that AMVI Medical Group ("AMVI") has contracted with ApolloMed ACO to participate in its Accountable Care Organization.

19 Oct 2013

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).

19 Oct 2013

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).

19 Oct 2013

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Each week, KHN compiles a selection of recently released health policy studies and briefs.

19 Oct 2013

OBHG ranks 5th place in size category in Best Places to Work in South Carolina Program

Ob Hospitalist Group (OBHG) has been ranked 5th in their size category in the Best Places to Work in South Carolina Program sponsored byThe South Carolina Chamber of Commerce, Best Companies Group and the publishers of SCBIZ News.

19 Oct 2013

Healthcare News and Research

Latest Healthcare News and Research

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

First Edition: October 21, 2013

WebMD signs agreement to repurchase all shares from Icahn Group

New collaborative project aims to discover genes underlying rare genetic diseases

UL professor to lead €1.5M research programme on economics of personalised health

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

HOYA Group's Vision Care Division expands operations in Romania

GVI uses Toshiba’s Spot Fluoroscopy to reduce radiation exposure to patients and physicians

Researchers discover link between NOX4 enzyme and osteoporosis

Adolescents vaccination for pertussis linked with lower rates of infant hospitalizations

Research Institute receives Fast Track status for its gene therapy product for treatment of SMA

Tech experts say total overhaul of healthcare.gov may be needed

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Viewpoints: Health marketplace already has eligibility verification; entitlement fight lies ahead

Unitedhealth says lower Medicare advantage payments forced smaller profit

AMVI partners with ApolloMed to participate in Accountable Care Organization

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

OBHG ranks 5th place in size category in Best Places to Work in South Carolina Program

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in